QSAR analysis on benzodithiazine derivatives as HIV-1 integrase inhibitors

被引:0
|
作者
Ravichandran V [1 ]
Jain A [2 ]
Mourya V.K [3 ]
Agrawal R.K [2 ]
机构
[1] Department of Pharmaceutical Chemistry,Faculty of Pharmacy,AIMST University,Semeling,Kedah,Malaysia  2. Pharmaceutical Chemistry Research Laboratory,Dept.of Pharmaceutical Sciences,Dr.Hari Singh Gour
关键词
Human immunodeficiency virus; Integrase; Inhibition; Quantitative Structure Activity Relationship; Benzodithiazines;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective:Inhibition of HIV-1 integrase is an important strategy for the treatment of HIV and AIDS.There-fore, HIV-1 integrase inhibitory activity of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines has been analyzed with different physicochemical parameters.Methods:In the present work,quantitative structure activity relationship studies were performed on a series of benzodithiazines as HIV-1 integrase inhibitors using the modeling software Win CAChe version 6.1.Multiple linear regression analysis was performed to derive quantitative structure activity relationship models which were further evaluated for statistical significance and predictive power by internal and external validation.Results:The best QSAR models were having good correlation coefficient (r) with low standard error of estimation(SEE) and cross validated square of correlation coefficient (q~2 ).The robustness of the models was checked by Y-randomization test and they were identified as good predictive models.The model for HIV integrase(wt) inhibitory activity of benzodithiazines suggest that the increase of dipole moment(Z) of molecules leads to reduce 3’processing and strand transfer inhibitory activity, substitution with high electro positive groups is conducive for the 3’processing inhibitory activity,and the increase in heat of formation is favorable for 3 -processing and strand transfer inhibitory activity.Conclusion: The model for HIV integrase(C65s) inhibitory activity of benzodithiazines suggest that the increase of dipole moment(X) of molecules leads to reduce 3’processing and strand transfer inhibitory activity,and the substitution with high hydrophobic groups is conducive for the 3’processing and strand transfer inhibitory.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 50 条
  • [21] QSAR studies of HIV-1 integrase inhibition
    Yuan, HB
    Parrill, AL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (12) : 4169 - 4183
  • [22] 3D-QSAR and molecular modeling of HIV-1 integrase inhibitors
    Makhija, MT
    Kulkarni, VM
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (03) : 181 - 200
  • [23] Docking and 3D-QSAR studies of HIV-1 integrase inhibitors
    Sharma, Horrick
    Cheng, Xiaolin
    Patil, Shivaputra
    Buolamwini, John K.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [24] 3D-QSAR and molecular modeling of HIV-1 integrase inhibitors
    Mahindra T. Makhija
    Vithal M. Kulkarni
    [J]. Journal of Computer-Aided Molecular Design, 2002, 16 : 181 - 200
  • [25] QSAR-based drug designing studies on HIV-1 integrase inhibitors
    Singh S.P.
    Deb C.R.
    Kakati L.N.
    Konwar B.K.
    [J]. Network Modeling Analysis in Health Informatics and Bioinformatics, 2016, 5 (1)
  • [26] Eigen value analysis of HIV-1 integrase inhibitors
    Makhija, MT
    Kulkarni, VM
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (06): : 1569 - 1577
  • [27] The hunt for HIV-1 integrase inhibitors
    Lataillade, Max
    Kozal, Michael J.
    [J]. AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
  • [28] The future of integrase inhibitors of HIV-1
    Malet, Isabelle
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
  • [29] Arylamide inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Mazumder, A
    Sunder, S
    Pommier, Y
    Burke, TR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194
  • [30] Thiazolothiazepine inhibitors of HIV-1 integrase
    Neamati, N
    Turpin, JA
    Winslow, HE
    Christensen, JL
    Williamson, K
    Orr, A
    Rice, WG
    Pommier, Y
    Garofalo, A
    Brizzi, A
    Campiani, G
    Fiorini, I
    Nacci, V
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341